Search the Newsreel

Form 8K Arcadia Biosciences Inc For: 13 August By Investing.com

This article reports on the filing of a Form 8K by Arcadia Biosciences Inc. on August 13. The company's stock symbol is RKDA, and its shares experienced a 9.60% increase. The brief announcement provides no further details about the content of the 8K filing.

Arcadia Biosciences: Q2 Earnings Snapshot

374Water and Arcadis Team Receives U.S. Department of Defense Success Memo Opening Pathway for AirSCWO(TM) Technology for PFAS Destruction at Commercial Scale

The DoD Success Memo enables government contracting officers to rapidly procure goods and services across all Federal agencies, accelerating deployment of 374Water's AirSCWO technology into the large and growing Federal marketplace. MORRISVILLE, NC / ACCESS Newswire / August 13, 2026 / 374Water Inc. (NASDAQ:SCWO) …

Arcadia Biosciences, Inc. SEC Filing (Aug 10, 2026)

This article reports on an SEC filing by Arcadia Biosciences, Inc. (RKDA) on August 10, 2026. The filing is an ARS type and its impact is assessed as low with a neutral sentiment. The document is available as a PDF and further details about …

Arcadia Biosciences Disclosed Failure to Satisfy a Continued Listing Rule or Standard

Arcadia Biosciences (RKDA) received a Nasdaq notice on August 4, 2026, indicating non-compliance with the $1.00 minimum bid price rule. The company's stock has traded below this threshold for 30 consecutive business days. Arcadia Biosciences has 180 days, until February 1, 2027, to regain …

Arcadia Biosciences Inc (RKDA) Stock News Today

This article provides current stock information for Arcadia Biosciences Inc (RKDA), showing its latest trading price and daily performance. It notes that more news and analysis for the company will be available soon. The page also includes general information about the company's financials, stock …

Arcadia Biosciences (RKDA) faces Nasdaq $1.00 bid-price deficiency and potential delisting risk

Arcadia Biosciences (RKDA) has received a notice from Nasdaq regarding non-compliance with the minimum bid price requirement of $1.00 per share. The company's stock traded below this threshold for 30 consecutive business days, leading to potential delisting risk. RKDA has an initial 180-day period, …

Arcadia Biosciences Inc (RKDA) Earnings Forecast: Future EPS & Revenue Growth Estimates

This article provides an earnings forecast for Arcadia Biosciences Inc (RKDA), detailing its current stock price, market capitalization, and analyst ratings. Based on one analyst, the company has a "Buy" rating with a target price of $12.00, representing a significant upside. The report also …

Arcadia Biosciences Inc (RKDA) Financial Health: Profitability & Balance Sheet Analysis

Arcadia Biosciences Inc (RKDA) currently holds a financial score of 6.21, ranking 76th out of 94 companies in the Food & Tobacco industry. The company's financial status is considered robust, but its operating efficiency is low. Its recent quarterly revenue was $1.10M, marking an …

Verdeca gets USDA nod for HB4 drought tolerant soybeans

Verdeca, a joint venture of Arcadia Biosciences and Bioceres Crop Solutions, has received USDA approval for its HB4 drought-tolerant soybeans, allowing for commercialization in the U.S. This follows FDA approval in 2017. The HB4 trait is now approved in over 80% of the global …

Arcadis (ENXTAM:ARCAD) Stock Looks Fairly Valued After Recent Gains

Track your investments for FREE with Simply Wall St, the portfolio command center trusted by over 7 million individual investors worldwide. Arcadis stock has climbed 18.7% over the past month, yet the valuation checks point to a more balanced picture rather than a clear …

RKDA|Arcadia Biosciences Inc|Price:0.625|Chg%:-0.008

This article provides a comprehensive stock analysis of Arcadia Biosciences Inc (RKDA) from TradingKey. It highlights that RKDA has relatively healthy fundamentals and significant growth potential, although its valuation is considered fair within the Food & Tobacco industry. The stock is currently trading sideways, …

Arcadis unanimously rejects second unsolicited proposal from WSP Global Inc

Arcadis N.V. Press Release Arcadis unanimously rejects second unsolicited proposal from WSP Global Inc. Amsterdam, July 30, 2026 – Arcadis (EURONEXT: ARCAD) (the "Company") the world's leading company delivering data-driven sustainable design, engineering, and consultancy solutions for natural and built assets, announces that its …

Arcadis Q2 and Half Year 2026 Results: Strong momentum for the next phase of profitable growth. Strategic targets in place for 2027-2029

Arcadis N.V. Press Release | Arcadis Half Year 2026 Results & 2027-2029 Strategy Strong momentum for the next phase of profitable growth: strategic targets in place for 2027-2029 FINANCIAL RESULTS Organic net revenue growth step up to 2.2% for Q2'26, 1.5% for H1'26, reflecting …

Arcadia Biosciences Inc (RKDA) Institutional Confidence

This article provides details on the institutional confidence score for Arcadia Biosciences Inc (RKDA), which stands at 3.00, unchanged from its previous score. It lists key institutional shareholders and their recent activity, including shares held and percentage change. The data highlights institutional investor holdings …

FCM Travel secures landmark 10-year global partnership with Arcadis

SYDNEY, July 29, 2026 /PRNewswire/ -- FCM Travel has re-signed global design and consultancy organisation Arcadis to an industry-defining 10-year contract.FCM Travel logo The agreement represents a significant long-term commitment in the travel management sector and solidifies a partnership built on shared innovation and …

Arcadia Biosciences Inc (RKDA) Cash Flow

This article provides a detailed cash flow statement for Arcadia Biosciences Inc (RKDA), covering quarterly and annual data for operating, investing, and financing activities. It presents key financial figures, year-over-year changes, and includes an FAQ section explaining different types of cash flow and RKDA's …

Arcadia Biosciences Inc (RKDA) Risk Assessment: Volatility, Financial Risk & Investment Risk

This article provides a risk assessment for Arcadia Biosciences Inc (RKDA), noting its current risk score of 1.33, ranking 81 out of 93 in the Food & Tobacco industry. The company's beta of 0.51 suggests it is less volatile than the S&P 500. The …

Arcadia Biosciences Inc (RKDA) Income Statement

Arcadia Biosciences Inc (RKDA) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution

This article provides a revenue breakdown for Arcadia Biosciences Inc (RKDA), highlighting its regional revenue contributions. While specific business segment data and profit contributions are not yet disclosed, the report shows the United States as a primary revenue source. This information is intended for …

Arcadia Biosciences, Inc. Revenue Breakdown – FWB:17D

Arcadia Biosciences, Inc. (FWB:17D) generated 4.14 million EUR in revenue last year, primarily from its Zola and Gamma Linolenic Acid Products segment. This figure is down from 4.84 million EUR in the previous year. The United States was the largest contributor to revenue, accounting …

Arcadis toll system powers critical North American trade gateway at Gordie Howe International Bridge

Arcadis delivers end-to-end toll system and provides intelligent systems design across transportation, security, and communications for landmark $6.4B Gordie Howe International Bridge WINDSOR, ON and DETROIT, July 27, 2026 /PRNewswire/ -- Arcadis (EURONEXT: ARCAD), a global leader in sustainable design, engineering, and consultancy solutions …

Arcadia Biosciences Inc (RKDA) Balance Sheet

This article presents the detailed balance sheet for Arcadia Biosciences Inc (RKDA), offering quarterly and annual financial data spanning several years. It allows investors to analyze the company's financial health, liquidity, leverage, and return on equity through various metrics like cash, total assets, liabilities, …

Arcadia Biosciences Inc (RKDA) Shareholder Structure: Major Shareholders & Institutional Holdings

This article details the shareholder structure of Arcadia Biosciences Inc (RKDA), highlighting its major shareholders and institutional holdings. It provides data on the proportion of shares held by various investment advisors, hedge funds, and individual investors, alongside a breakdown of institutional shareholding trends over …

Arcadia Biosciences Inc (RKDA) Dividends & Stock Splits: Historical Payouts and Event Timeline

This article provides historical data on dividends and stock splits for Arcadia Biosciences Inc (RKDA). It indicates that the company has not distributed any dividends over the past five years but shows a series of merger-related stock splits on February 28, 2023, with a …

RKDA|Arcadia Biosciences Inc|Price:0.550|Chg%:-0.150

Arcadia Biosciences Inc (RKDA) Technical Analysis: Support, Resistance, Indicators & Moving Averages

This article provides a technical analysis of Arcadia Biosciences Inc (RKDA), highlighting its current price momentum score of 4.81 and its ranking in the Food & Tobacco industry. It details support and resistance levels, and presents an overview of various technical indicators like MACD, …

WSP confirms submission of non-binding indicative expression of interest to Arcadis N.V. to acquire all issued and outstanding shares in the capital of Arcadis N.V. for an offer price of EUR 51.50 per share

Groupe WSP Global Inc. WSP submitted an indicative non-binding proposal to acquire all issued and outstanding shares in the capital of Arcadis on July 23, 2026 Intended offer consideration of EUR 51.50 per ordinary share (cum dividend) A combination of WSP and Arcadis, if …

Arcadis receives second unsolicited proposal from WSP after having rejected an earlier unsolicited proposal

Arcadis N.V. PRESS RELEASE ARCADIS RECEIVES SECOND UNSOLICITED PROPOSAL FROM WSP AFTER HAVING REJECTED AN EARLIER UNSOLICITED PROPOSAL, WHICH FUNDAMENTALLY UNDERVALUED THE COMPANY AND ITS FUTURE PROSPECTS Amsterdam, July 24 2026 – Arcadis (EURONEXT: ARCAD), the world's leading company delivering data-driven sustainable design, engineering, …

U.S. Army Corps of Engineers Validates 374Water's AirSCWO(TM) Technology at 99.9993% PFAS Destruction in Report on AFFF Treatment

Independently validated USACE Engineer Research and Development Center ("ERDC") demonstration - conducted with Arcadis - confirms permanent destruction of PFAS in aqueous film-forming foam ("AFFF"), with treated liquid effluent below U.S. EPA drinking water limits and near-zero fluorinated stack emissions. MORRISVILLE, NC / ACCESS …

Arcadia Biosciences stock trades quietly as investors weigh 2023 revenue shift and balance sheet cha

Arcadia Biosciences (RKDA) saw its stock trade quietly as investors considered its 2023 financial performance. The company experienced a revenue decline to $7.4 million in 2023 from $9.5 million in 2022, but notably achieved a positive gross margin for the first time, signaling improved …

Up 155% in a Year, Up 46% in a Day: Inside Arcadia Minerals' (ASX:AM7) Remarkable Critical Minerals Rally

Arcadia Minerals Limited (AM7.AX) stock price, news, quote and history